Bruce Hiscock Purchases 61 Shares of Bioventix PLC (LON:BVXP) Stock

Bioventix PLC (LON:BVXP - Get Free Report) insider Bruce Hiscock acquired 61 shares of Bioventix stock in a transaction dated Monday, December 23rd. The stock was purchased at an average cost of GBX 273 ($3.42) per share, for a total transaction of £166.53 ($208.76).

Bruce Hiscock also recently made the following trade(s):

• On Friday, November 22nd, Bruce Hiscock purchased 24 shares of Bioventix stock. The shares were acquired at an average cost of GBX 3,822 ($47.91) per share, for a total transaction of £917.28 ($1,149.91).
• On Wednesday, October 30th, Bruce Hiscock acquired 300 shares of Bioventix stock. The stock was acquired at an average cost of GBX 3,330 ($41.75) per share, with a total value of £9,990 ($12,523.51).

Bioventix Stock Performance

Shares of LON:BVXP traded down GBX 25.25 ($0.32) during midday trading on Tuesday, hitting GBX 3,174.76 ($39.80). 3,559 shares of the company's stock traded hands, compared to its average volume of 5,800. The firm's fifty day moving average price is GBX 3,634.44 and its two-hundred day moving average price is GBX 3,989.98. Bioventix PLC has a twelve month low of GBX 2,977 ($37.32) and a twelve month high of GBX 5,100 ($63.93). The company has a market cap of £165.72 million, a PE ratio of 1,947.70 and a beta of 0.35.

Bioventix Increases Dividend

The business also recently announced a dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th were paid a GBX 87 ($1.09) dividend. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. This is a positive change from Bioventix's previous dividend of $68.00. Bioventix's dividend payout ratio (DPR) is 9,693.25%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.